Stevanato Group S.p.A. (STVN) Insider Federici Buys 4,975 Shares

Insider Buying and Selling at Stevanato Group S.p.A.

William Federici, a notable insider at Stevanato Group S.p.A. (NYSE: STVN), bought 4,975 shares on June 12, 2026. At a share price of $18.39, this purchase is valued at approximately $91,500. This move comes amid other recent insider activity at the company, particularly by Chief Business Strategy Officer Mauro Stocchi, who made a notable purchase of 6,586 shares just a few days prior on June 9.

Recent Insider Transactions

On June 12, 2026, several other insiders also made moves. Sue-Jean Lin, Karen Flynn, and Elisabetta Magistretti each bought 4,975 shares on the same day as Federici. Meanwhile, CFO Dal Lago Marco sold 7,997 shares on June 12. This mix of buying and selling among insiders suggests varying levels of confidence in the company's future.

Stock Performance Context

Stevanato Group's stock is currently trading at $18.39, which is significantly lower than its 52-week high of $27.99. The shares have been under pressure, hovering around their 50-day moving average of $20.98. Investors might be watching for a rebound, especially with the stock's performance well below its recent highs.

Analysts Set New Price Targets

Analysts have mixed views on Stevanato Group. On September 9, 2026, UBS maintained a Neutral rating on the stock but lowered its price target from $28.00 to $23.00. This reflects a cautious approach to the stock's potential, as analysts continue to assess its growth prospects amid recent market trends.

What Stevanato Group S.p.A. Does

Stevanato Group S.p.A. designs and manufactures medical instruments and supplies, primarily for the biopharma and healthcare sectors. The company has a market capitalization of about $5.26 billion and operates in a competitive environment, providing innovative solutions for drug delivery and diagnostics.

What to Watch at Stevanato Group S.p.A.

Investors should keep an eye on the upcoming earnings report scheduled for November 5, 2026, which will provide insight into the company's performance and future outlook. Additionally, the recent insider activities may signal confidence in the company's direction, although the mixed analyst ratings suggest a need for caution. Remember, the 13F filings reflect past holdings and may not represent current positions.